Casaevades

Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso
Last updated 14 junho 2024
Study provides new look at why rare cancer often evades treatments
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
Cancers, Free Full-Text
Study provides new look at why rare cancer often evades treatments
CRISPR in Cancer Therapeutics: CAR T, NK, TCR and Beyond
Study provides new look at why rare cancer often evades treatments
Spatial transcriptomics—the next evolution of cancer drug discovery - 10x Genomics
Study provides new look at why rare cancer often evades treatments
Using genomics to guide personalized cancer treatment
Study provides new look at why rare cancer often evades treatments
How liquid biopsies have made it easier to treat cancer
Study provides new look at why rare cancer often evades treatments
New technique could help make precision medicine more widely available
Study provides new look at why rare cancer often evades treatments
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Study provides new look at why rare cancer often evades treatments
Organoids study finds potential new treatment for pulmonary neuroendocrine tumors
Study provides new look at why rare cancer often evades treatments
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Study provides new look at why rare cancer often evades treatments
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
Study provides new look at why rare cancer often evades treatments
IJMS, Free Full-Text
Study provides new look at why rare cancer often evades treatments
Answers to Unsolved Rare Disease Mysteries May Be on the Horizon
Study provides new look at why rare cancer often evades treatments
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing
Study provides new look at why rare cancer often evades treatments
Scientists Uncover How Proteins Drive Cancer Growth
Recomendado para você
você pode gostar

© 2014-2024 rahh.de. All rights reserved.